 |
Welcome - Richard Murphy, Ph.D.
·President and Chief Executive Officer,
Salk Institute for Biological Studies |
Dr. Murphy became president and chief executive officer of the Salk Institute in October 2000. Prior to heading the Salk, for eight years he directed the Montreal Neurological Institute (MNI), a teaching and research institute of McGill University, where he was also professor of neurology and neurosurgery.
Dr. Murphy began his academic career at the Harvard University Medical School following postdoctoral studies at Massachusetts General Hospital. A member of Harvard’s Department of Cell Biology and Anatomy from 1976 through 1986, he won numerous teaching awards and conducted an active research program in neurotrophins, proteins that promote the growth and survival of nerve cells and appear to play a role in memory.
He left Harvard in 1986 to chair the Department of Anatomy and Cell Biology at Canada’s University of Alberta. While continuing his own research, he restructured the department and amassed a record of achievement that led to his appointment as MNI director. \
At the Salk Institute, Dr. Murphy has worked with faculty and trustees to develop a strategic plan to shape the Institute’s future scientific direction. Broadening the Institute’s current strengths by hiring a new generation of Salk scientists is central to the plan. Another priority has been to increase and enhance membership of the Salk’s board of trustees to reflect the Institute’s local, national, and international constituencies.
 |
Keynote Speaker - Laurie Zoloth, Ph.D.
·Director,
Center for Bioethics, Science and Society
·Professor of Medical Ethics and Humanities,
Northwestern University, Feinberg School of Medicine
·Professor of Religion and member
Jewish Studies,
Northwestern University, Weinberg College of Arts and Sciences |
Dr. Zoloth is director of the Center for Bioethics, Science and Society, professor of Medical Ethics and Humanities at Northwestern University, Feinberg School of Medicine, professor of Religion, and a member of the Jewish Studies faculty at Northwestern University, Weinberg College of Arts and Sciences. She directs bioethics at the Center for Genetic Medicine, the Center for Regenerative Medicine, and the Institute for Nanotechnology at Northwestern. In 2005, after two terms of service on NASA’s National Advisory Council, she received the NASA Public Service Medal. In 2001, she was president of the American Society for Bioethics and Humanities and in 2002 was vice-president of the Society for Jewish Ethics. Professor Zoloth is the chair of the Howard Hughes Medical Institute (HHMI). Bioethics Committee, a founding board member of the International Society for Stem Cell Research, a founding board member of the Society for Neuroethics, on NASA’s first Planetary Protection Advisory Committee, and on the boards of several national organizations, including the Society for Women’s Research and the Health Care Council of Hadassah. She is the co-chair of the American Academy of Religion Section on Women. She is the author of Health Care and the Ethics of Encounter: A Jewish Discussion of Social Justice, and is co-editor of two books on religion, science, and ethics including The Human Embryonic Stem Cell Debate, Notes from a Narrow Ridge: Religion and Bioethics and Margin of Error: The Ethics of Mistakes in the Practice of Medicine. In 2000, she was co-principal investigator for an NIH ELSI grant on identity, ethnicity, and citizenship after the Human Genome Project. She has published extensively in the areas of ethics, family, feminist theory, religion and science, Jewish Studies, and social policy. Her current research projects include work on the emerging issues in medical and research genetics and on the ethical issues in stem cell research, and her research interest in distributive justice in health care continues.
 |
Diane Beeson, Ph.D.
·Professor Emerita,
Department of Sociology and Social Services
California State University, East Bay
|
Dr. Beeson received her B.A. in Sociology from the University of California, Berkeley, and her M.A. and Ph.D. from the University of California San Francisco, where she specialized in medical sociology. She was a Pew post-doctoral fellow at the University of California San Francisco's Institute for Health Policy Studies from 1985-1987. Her main research interest for nearly three decades has been the social challenges of new reproductive technologies. For much of this time she was affiliated with UC Berkeley's Institute for the Study of Social Change researching social implications of genetic testing. In 1996 and 1997 she was a visiting scholar at Stanford University's Center for Genomics, Ethics and Society. She is currently an affiliated scholar with the Institute on Biotechnology and the Human Future at Chicago-Kent College of Law/Illinois Institute of Technology. She has served as a consultant on projects related to genetic testing for numerous organizations, including the National Society of Genetic Counselors, National Institutes of Health, and the U.S. Department of Energy. She has served on peer review committees for the National Human Genome Research Institute and has authored numerous articles in professional journals and anthologies.
 |
R. Alta Charo, J.D.
·Warren P. Knowles Professor of Law & Bioethics,
University of Wisconsin at Madison |
R. Alta Charo is the Warren P. Knowles Professor of Law and Bioethics at the University of Wisconsin at Madison, where she is on the faculty of the Law School and the Medical School's Department of Medical History and Bioethics. She also serves on the faculty of the UW Masters in Biotechnology Studies program and lectures in the MPH program of the Department of Population Health Sciences. In 1994 Professor Charo served on the NIH Human Embryo Research Panel, and from 1996-2001, she was a member of President Clinton's National Bioethics Advisory Commission. In 2005, she was elected as a fellow of the Wisconsin Academy of Sciences, Arts and Letters and in 2006 she was elected to membership in the National Academies' Institute of Medicine.
Professor Charo serves on several expert advisory boards of organizations with an interest in stem cell research, including CuresNow, the Juvenile Diabetes Research Foundation, the International Society for Stem Cell Research, and WiCell, as well as on the advisory board to the Wisconsin Stem Cell Research Program. In 2005, she was appointed to the ethics standards working group of the California Institute for Regenerative Medicine. Also in 2005, she helped to draft the National Academies' Guidelines for Embryonic Stem Cell Research, and in 2006 she was appointed to co-chair the National Academies' Human Embryonic Stem Cell Research Advisory Committee.
 |
Mary Devereaux, Ph.D.
·Director,
Biomedical Ethics Seminar Series
Research Ethics Program
University of California San Diego |
Dr. Devereaux, with a Ph.D. in philosophy, specializes in biomedical, research, and stem-cell ethics. She is a member of the Research Ethics Program at UCSD, a fellow with the Center for Ethics in Science and Technology, and co-founder and director of the UCSD Biomedical Ethics Seminar Series, a monthly meeting of research scientists, medical clinicians, philosophers and administrators to discuss issues such as human subject research, informed consent, conflict of interest, and end-of-life issues. She also directs “Tough Cases,” a monthly seminar in medical ethics.
With Michael Kalichman, director of the Research Ethics Program, Dr. Devereaux provides ethics training and resources for the San Diego Research Ethics Consortium. She lectures widely to academic, community, and business groups, seeking to explain the unusual social, legal, and ethical challenges of human embryonic stem cell research. Central to her approach is a commitment to moving beyond polarizing debates by working to build community and national consensus regarding stem cell research. Dr. Devereaux is a member of the Hospital Ethics Committee at UCSD Medical Center, the IRB/ESCRO Committee at the Burnham Institute, and the ESCRO Committee at the Salk Institute. At UCSD, she provides ethics training to graduate students in the sciences, the School of Medicine, and Skaggs School of Pharmacy.
Dr. Devereaux took the opportunity to gain some first hand experience in stem cell biology, doing embryonic stem cell training at the Burnham Institute. Her time in the lab provided a practical real-life perspective for explaining and dealing with the ethical and regulatory issues facing research scientists and clinicians. Recent publications address ethical issues raised by embryonic stem cell research, cosmetic surgery and other forms of medical enhancement, and prenatal testing. Dr. Devereaux is currently at work on a project examining ethical issues related to oocyte donation for research.
 |
Lawrence S. Goldstein, Ph.D.
·Professor,
Cellular and Molecular Medicine
·Director, Stem Cell Program
University of California San Diego
·Investigator, Howard Hughes Medical Institute |
Dr. Goldstein is professor of Cellular and Molecular Medicine at the University of California San Diego, School of Medicine, and director of the UC San Diego Stem Cell Program. He is also an investigator with the Howard Hughes Medical Institute (HHMI). Dr. Goldstein has been with the UCSD School of Medicine since 1993. A UCSD alumnus, he received his B.A. degree in biology and genetics from UCSD in 1976 and his Ph.D. degree in genetics from the University of Washington, Seattle in 1980. He did postdoctoral research at the University of Colorado at Boulder from 1980 to 1983 and the Massachusetts Institute of Technology in 1983-1984. He was assistant, associate, and full professor at Harvard University in the Department of Cellular and Developmental Biology from 1984 to 1993, when he moved to UCSD and HHMI. His awards include a Senior Scholar Award from the Ellison Medical Foundation, an American Cancer Society Faculty Research Award, and the Loeb Chair in Natural Sciences when he was at Harvard University. His work is supported by funding from HHMI, the National Institutes of Health (NIH), the Johns Hopkins ALS Center, ALSA, and the HighQ Foundation. Dr. Goldstein's research is focused on understanding the molecular mechanisms of movement inside brain cells and how failures in the movement systems may lead to neurodegenerative diseases. His laboratory has discovered important links between transport processes and diseases such as Alzheimer's and Huntington's diseases. Dr. Goldstein has had an active role in national science policy, having served on many public scientific advisory committees, in addition to serving as an expert commentator on the issue of stem cell research and biomedical research policy by print and broadcast media. He has testified on a number of occasions in the U.S. House of Representatives and the Senate about NIH funding and stem cell research. Dr. Goldstein also served as co-chair of the scientific advisory committee to the campaign for the Proposition 71 stem cell research initiative, which authorizes $3 billion in tax-free state bonds to fund stem cell research in California over the next 10 years. As a co-founder and consultant of the biotechnology company Cytokinetics, he has also had an active role in private industry where he has gained experience in translating scientific insights to new therapeutic approaches.
 |
Sidney Golub, Ph.D.
·Professor Emeritus,
Microbiology and Molecular Genetics
University of California Irvine, School of Medicine |
Dr. Golub received his B.A. from Brandeis University and his Ph.D. in microbiology from Temple University School of Medicine. He was a Damon Runyon Memorial Fund Postdoctoral Fellow at the Department of Tumor Biology of the Royal Karolinska Institute in Stockholm, Sweden, where he studied cancer immunology in the world famous laboratory of Dr. George Klein. Dr. Golub was appointed to the faculty of the UCLA School of Medicine in 1971. He rose from assistant professor to associate professor and was promoted to full professor in the UCLA Departments of Surgery (Division of Oncology) and Microbiology & Immunology. His research focused on the functions of the immune system in cancer patients. He has more than 150 publications, two patents, and was the recipient of the Jonsson Prize for cancer research.
In his administrative career at UCLA, Dr. Golub served as associate dean of the School of Medicine (1986-1992) with responsibilities in academic personnel and programs. He was the interim dean and provost of the UCLA School of Medicine from 1992-1994. From 1994 to 1998, he served as executive vice chancellor at the University of California Irvine. As such, he was the campus’ chief academic and budget officer. From 1999 to 2003, Sidney Golub served as the executive director of the Federation of American Societies for Experimental Biology (FASEB). FASEB is the oldest and largest national organization of biomedical research scientists, representing nearly 70,000 investigators. After his retirement from FASEB in late 2003, Golub returned to California where he chairs the UCI Human Stem Cell Research Oversight Committee. In addition to his activities on the UCI faculty, he has served as a consultant for other institutions of higher education and he is a member of the board of trustees of Smith College in Northampton, Massachusetts.
 |
Lawrence M. Hinman, Ph.D.
·Co-Director, Center for Ethics in Science and Technology
·Professor, Philosophy Department
·Director, Values Institute
University of San Diego
|
Dr. Hinman is director of the Values Institute and professor of Philosophy at the University of San Diego, where he has been teaching since 1975. He is co-founder with Dr. Kalichman of the Center for Ethics in Science and Technology. Dr. Hinman is the author of two widely-used texts in ethics, Ethics: A Pluralistic Approach to Moral Theory, 3rd ed. (Wadsworth , 2002) and Contemporary Moral Issues, 3rd ed. (Prentice-Hall, 2005). He has published numerous scholarly articles in ethics in journals such as Ethics, The Monist, Philosophy and Phenomenological Research, Philosophical Studies, Australasian Journal of Philosophy, Criminal Justice Ethics, Computers and Society, Ethics and Information Technology, and Teaching Philosophy; he has also contributed to numerous anthologies in ethics. Translations of his articles have appeared in German and Italian. He also publishes op-ed pieces in newspapers such as the Los Angeles Times, the Washington Post and the San Diego Union-Tribune. Dr. Hinman is also actively engaged in developing Ethics Across the Curriculum (EAC) programs at the University of San Diego and around the country. As part of the USD EAC program, he has brought such notable speakers to USD as Carol Gilligan, Daniel Callahan, Michael Walzer, and Michael Josephson. Most recently, he has been developing ethics-related workshops and components for middle school and high school students in the Pacific Northwest. He has received several grants in this area. He has also organized several major conferences in philosophy, including “Kantian Ethics: Interpretations and Critiques” (January 2003). Dr. Hinman is a former member of the board of the American Philosophical Association and also a past member of the Executive Committee of the Association for Practical and Professional Ethics. He has served as a member of the APA Committee on Computing and Philosophy and chaired the APA Committee on Teaching and Philosophy in 2003-05, and for several years was on the Steering Committee for the Computing and Philosophy (CAP) Conference at Carnegie-Mellon.
 |
Michael Kalichman, Ph.D.
·Co-Director, Center for Ethics in Science and Technology
·Director, Research Ethics Program
University of California San Diego
·Director,
San Diego Research Ethics Consortium |
Dr. Kalichman first taught about research ethics in 1988. After teaching a variety of courses and seminars in research ethics for graduate students and postdocs, he became the founding director of the UCSD Research Ethics Program in 1997. Kalichman has been an invited participant or speaker at many meetings and workshops, including: “Data Management in Biomedical Research” (Dept. Health and Human Services, 1990); “Biomedical Research Integrity in the ‘90s” (sponsored by NIH, AAMC, and UCSD, San Diego, 1990); “The Responsible Conduct of Research: A Commitment for all Scientists” (PRIM&R, San Diego, 1996); “Teaching Responsible Science” (National Academy of Sciences, 1997); “Educating for the Responsible Conduct of Research in the New Millennium” (PRIM&R, Bethesda, 1999); review of a proposed PHS Policy on Instruction in the Responsible Conduct of Research (Office of Research Integrity, 2000); RCR experts invited to consult with NIH on evaluating the training grant RCR requirement (Bethesda, 2003); biosecurity education for biology researchers (Federation of American Scientists, 2004); and drafting of a code for the conduct of dual use research (National Science Advisory Board on Biosecurity, 2006). He is the creator of a Web-based resource to help institutions develop programs of instruction in the responsible conduct of research (http://rcrec.org/r) and leads an NIH-funded project to assess the effectiveness of teaching research ethics. Dr. Kalichman is co-chair of a national organization to promote responsible conduct of research education, the Responsible Conduct of Research Education Committee (RCREC, http://rcrec.org), co-director and co-founder of the San Diego Center for Ethics in Science and Technology, director and founder of the San Diego Research Ethics Consortium, and co-chair of the UCSD Embryonic Stem Cell Research Oversight Committee.
 |
Hans S. Keirstead, Ph.D.
·Associate Professor,
Reeve-Irvine Research Center
·Co-Director,
Stem Cell Research Center
University of California Irvine |
The Canadian-born neuroscientist received his Ph.D. from the University of British Columbia in Vancouver, Canada. His Ph.D. thesis concerned his invention of a novel method for regenerating damaged spinal cords, and formed the basis of several worldwide patents as well as the formation of a company in 1999. This work constituted the first demonstration of functional regeneration of the injured adult spinal cord, and for his achievements he received the Cameron A ward for the outstanding Ph.D. thesis in Canada. Dr. Keirstead then moved to Cambridge, England, where he conducted four years of Post-Doctoral studies at the University of Cambridge furthering his studies of spinal cord injury and beginning studies of multiple sclerosis. He was a warded Canadian and British Fellowships to support this work. He received the distinct honor of election to two senior academic posts, Fellow of the Governing Body of Downing College, and Senate Member of the University of Cambridge, and was the youngest member to be elected to those positions. In 2000, Dr. Keirstead joined the Reeve-Irvine Research Center at the University of California at Irvine. The Reeve-Irvine Research Center, founded by the late Christopher Reeve and philanthropist Joan Irvine, is a leading center for spinal cord injury research. Keirstead directs a large team investigating the cellular biology and treatment of spinal cord trauma, research that also has significance for multiple sclerosis and other diseases of the nervous system. In order to bring his treatments to clinical trials, he has founded or partnered with biotechnology companies to fund and conduct pre-clinical and clinical development. Dr. Keirstead was recently a warded the Distinguished Assistant Professor of UCI A ward, the UCI Academic Senate's highest honor, and was thereafter promoted to associate professor with tenure. In 2005, he was a warded the UCI Innovation A ward for innovative research leading to corporate and clinical development.
Dr. Keirstead has testified at Federal and California Senate Hearings on several occasions regarding the potential of stem cells, is an avid scientific correspondent for public education, is on the Editorial Board of three major journals, was an advisor to the California government on stem cell policy, was a Scientific Advisory Committee Member of the California Stem Cell Initiative that authored Proposition 71, and maintains working relationships with several stem cell companies, venture capital groups, and government economic development offices in the United States, Sweden and Norway.
Dr. Keirstead is also vice chancellor of Academic Development at UDECOM (Université pour le Développement Communautaire) situated in Guinea, Africa. UDECOM grants bachelors and Ph.D. degrees for community development in rural Africa. Keirstead leads several efforts to develop the university and improve the quality of life for those in the surrounding communities.
 |
Geoffrey Lomax, Dr.P.H.
·Senior Officer,
Medical and Ethical Standards Working Group
California Institute for Regenerative Medicine (CIRM) |
Dr. Lomax is the senior officer for the Medical and Ethical Standards Working Group for the California Institute for Regenerative Medicine. In this position, he provides program support for the development of CIRM’s medical and ethical standards. He worked previously as the research director with the California Environmental Health Investigations Branch to publish a strategic plan for the development of an Environmental Health Surveillance System in California. He subsequently worked to secure federal funding to implement aspects of the strategic plan resulting in the development of the California Environmental Health Tracking Program.
In 2002, he completed his Dr.P.H. research into the scientific, ethical, legal, and policy issues related to workplace biomonitoring and genetic testing. Through his professional career and publications, Dr. Lomax has continually worked to bridge issues of scientific policy and ethics in the development of state-based public health programs and research. His Dr.P.H. research and M.P.H. work were performed within the Division of Environmental Health Sciences at the University of California at Berkeley and his B.S. in Environmental Toxicology was conferred by the University of California at Davis.
 |
Jeanne F. Loring, Ph.D.
·Director,
NIH Human Embryonic Stem Cell Training Course
·Co-Director,
NIH Exploratory Center for Human Embryonic Stem Cell Research
Burnham Institute for Medical Research |
Dr. Loring was born in Tucson, Arizona, and grew up in Colorado, Utah, New Mexico, and Wyoming. She holds a B.S. in Molecular Biology from the University of Washington and a Ph.D. in Developmental Neurobiology from the University of Oregon. She served on the faculty of the University of California at Davis, where she taught courses in Embryology, then held research and management positions at biotechnology companies including Hana Biologics, GenPharm International, Incyte Genomics, and Arcos BioScience. She joined the faculty of the Burnham Institute as a principal investigator in January 2004 and serves as director of the NIH Human Embryonic Stem Cell Training Course and co-director of the institute's NIH Exploratory Center for Human Embryonic Stem Cell Research.
Dr. Loring has authored many scientific articles in the fields of neurobiology, embryology, and molecular biology, and is inventor on four issued patents and five patent applications. She served from 1995 to 2005 on an NIH Clinical Neurosciences study section, is a member of the Advisory Council of the Alzheimer’s Association and the Regulatory and Ethics Board for the Bill and Melinda Gates Foundation Global Challenge, and serves on the scientific advisory boards of several stem cell and instrument companies.
Dr. Loring has three main scientific interests: developing human embryonic stem cells for drug discovery, drug delivery, and cell therapy; using high information-content molecular approaches to characterize human disease; and discovering novel therapies for Alzheimer’s disease.
In the last several years, Dr. Loring has also focused on resolving the scientific, ethical, and legal issues that hinder the progress of human embryonic stem cell research. She founded the privately supported Stem Cell Community, a website for sharing information about human embryonic stem cells, and co-founded the Stem Cell Resource, which provides the practical and ethical infrastructure for donations of excess embryos for medical research. She and two non-profit organizations recently challenged the broad stem cell patents owned by the Wisconsin Alumni Research Foundation (WARF); the patents are undergoing re-examination in the US Patent Office.
 |
Ted W. Love, M.D.
Chairman and Chief Executive Officer,
Nuvelo, Inc. |
Dr. Love was appointed president and chief executive officer of Nuvelo, Inc. in March 2001, having been appointed president and chief operating officer of the company in January 2001. He has served as a director of the company since February 2001 and became chairman of the board in September 2005.
Dr. Love joined Nuvelo from Theravance Inc., where he served as senior vice president of development from February 1998 to January 2001. Previously, he spent six years at Genentech Inc., holding a number of senior management positions in Medical Affairs and Product Development. As vice president of Product Development and Regulatory Affairs at Genentech, Love oversaw all drugs in development including Herceptin, Rituxan, and TNKase. He also served as chairman of Genentech's Product Development Committee.
Dr. Love earned his bachelor's degree in molecular biology from Haverford College and his medical degree at Yale Medical School. He completed his residency and fellowship training in internal medicine and cardiology at Massachusetts General Hospital and Harvard Medical School. Following residency training, Love joined the faculty of Massachusetts General in the department of cardiology. He serves as a member of the boards of directors of Affymax, Inc., Santarus, Inc., the Biotechnology Institute, and the California Healthcare Institute. In addition, he serves on the Biotechnology Industry Organization's Health Section Governing Body and Emerging Company Section Governing Body and the 29-member California Independent Citizens' Oversight Committee (ICOC), which oversees the $3 billion allocated to stem cell research authorized by Proposition 71.
 |
David Magnus, Ph.D.
·Associate Professor,
Pediatrics and Medicine
Stanford University
·Director, Stanford Center for Biomedical Ethics
·Co-Chair, Stanford Hospital Ethics Committee |
Dr. Magnus is associate professor of Pediatrics and Medicine at Stanford University, where he is director of the Stanford Center for Biomedical Ethics and co-chair of the Ethics Committee for the Stanford Hospital. He received his Ph.D. in philosophy from Stanford University and has published articles on a range of topics in bioethics, particularly on issues concerning genetic technology, cloning, and stem cell research. He served on the National Research Council Ad Hoc Committee on the Bioconfinement of Genetically Engineered Organisms, and served as an “expert consultant” for the World Bank on food security and biotechnology and a consultant for the National Conference of State Legislators on cloning. In 2003-2004, he was a member of the Secretary of Agriculture’s Advisory Committee on Biotechnology in the 21 st Century. He currently serves on the California Human Stem Cell Research Advisory Committee. He is the principal editor of a collection of essays entitled Who Owns Life? (2002) and his publications have appeared in Science, Nature Biotechnology, and the British Medical Journal. He serves as associate editor of the American Journal of Bioethics. He has appeared on many television shows including “Good Morning America,” “CBS This Morning,” “FOX News Sunday,” and “ABC World News,” several nationally syndicated radio shows and has been quoted in Time, Newsweek, The Wall Street Journal, New York Times and USA Today among other publications. In addition to his scholarly work, he has published a number of editorial pieces in prominent newspapers.
 |
Ric Ross
·Clinical Embryologist and Laboratory Director,
La Jolla IVF and Smotrich Centre for Reproductive
Enhancement
·Director,
Stem Cell Resource
·Owner and Chief Technology Officer,
Stem Cell Therapeutic Technologies |
Mr. Ross is a certified clinical embryologist and laboratory director for La Jolla IVF and the Smotrich Centre for Reproductive Enhancement, working with Dr. David Smotrich. He is a director for the Stem Cell Resource, a non-profit embryo bank, as well as an owner and chief technology officer of Stem Cell Therapeutic Technologies, a private stem cell biotechnology company in La Jolla.
Ross grew up on and maintains a purebred cattle ranch in Canada, and early on found an interest in mammalian genetics. Early introduction of artificial insemination, embryo transfer, and in vitro fertilization on the ranch led him into seeking cutting edge technologies to improve the cattle herd.
He holds a double bachelors in Molecular Genetics from the University of Calgary and Animal Science from the University of Saskatchewan, as well as graduate degrees in Reproductive Physiology and Embryology, from the Western College of Veterinary Medicine. He did his post-graduate research at the University of Calgary in the Reproductive Medicine Research Department, then moved on to private industry building the in vitro fertilization program at Alta Genetics, a world renowned animal genetics company that pioneered the sciences of animal cloning, IVF, and genetic testing. Mr. Ross’s first experience in human reproductive technology was in 1996 when he was recruited by a friend who used to clone cows, and was then a laboratory director for a human IVF center in Los Angeles. The recruiting statement was “The science is the same…they just sue you instead of kicking you.” He was sold!!
Now 11 years, 12,000 cases, and 150,000 eggs later he discusses the process of ovarian stimulation, oocyte retrieval, embryo development, stem cell extraction, and the ethics and process of embryo donation.
 |
Duane J. Roth
·Chief Executive Officer,
CONNECT |
Mr. Roth is chief executive officer of CONNECT. CONNECT is the globally recognized, non-profit organization fostering entrepreneurship in the San Diego region by catalyzing, accelerating, and supporting the growth of the most promising technology and life sciences businesses. Focused on assisting start-up companies in the San Diego region, CONNECT has been directly involved with over 1,000 companies since its inception in 1985.
Prior to joining CONNECT, Roth founded Alliance Pharmaceutical Corp. where he still serves as chief executive officer and chairman of the board. Prior to founding Alliance, Mr. Roth held senior management positions at Johnson & Johnson and Wyeth operating companies. He has served as a member of the board of directors and executive committees of the Biotechnology Industry Organization (BIO), the California Healthcare Institute (CHI), and BIOCOM (past chair). Mr. Roth serves on a number of advisory committees and boards of the University of California, including the President’s Board on Science and Innovation, the UCSD Sulpizio Cardiovascular Center (past chair), the San Diego Science and Technology Council, the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, the Preuss Charter School (chair), and the UC San Diego Foundation Board (past chair). Mr. Roth is active in the San Diego community, serving on the board of the San Diego Regional Economic Development Corporation (past chair), the San Diego Regional Chamber of Commerce, the Lincoln Club of San Diego (past chair), the San Diego State University College of Business (past chair), San Diego State University Sciences & Engineering Deans' Advisory Board, and as co-chair of the Regional Housing Working Group. Governor Arnold Schwarzenegger appointed Mr. Roth to the Independent Citizens Oversight Committee (ICOC) for the California Institute of Regenerative Medicine (CIRM) and he also serves as a member on the Governor’s Commission for Jobs and Economic Growth. Mr. Roth is a graduate of Iowa Wesleyan College, where he serves as a trustee.
 |
Christopher Thomas Scott, Ph.D.
·Founding Executive Director, Program on Stem Cells in Society
·Senior Research Scholar,
Center for Biomedical Ethics
·Stem Cell Research Advisory Panel
·Stanford Writer-in-Residence
Stanford University |
Dr. Scott’s research centers on the social, economic, and ethical dimensions of stem cells. His book Stem Cell Now: A Brief Introduction to the Coming Medical Revolution (2006 Penguin) clearly explains the science, ethics, and politics of stem cell research for the lay reader.
Dr. Scott was the scientific founder of Acumen Sciences, a life sciences research company based in San Francisco and the founding executive editor of the award-winning Acumen Journal of Sciences, a magazine focused on the business, economics, and policy of life sciences. Prior to Acumen, he was the assistant vice chancellor at the University of California San Francisco. At UCSF he led an array of business and research units, including technology transfer, legal affairs, clinical research, and business development. He founded the UCSF Center for Biotechnology Education, a consortium approach to graduate training in entrepreneurship and the UCSF Innovation Accelerator, a life sciences start-up generator.
For nearly a decade Scott was a senior administrator at Stanford University. As associate director of the Center for Molecular Medicine, he worked with Nobel Laureate Paul Berg to develop one of the nation’s first translational medicine programs. He was the co-founder of ACCESS, a research unit devoted to clinical trials, and was director of Research Development for the Medical Center. He is one of only a handful of executives awarded for his contributions to Stanford’s research enterprise.
A businessman and bench scientist, Dr. Scott has spent 11 years in industry. He has principal founding relationships with several biotechnology start-ups. His undergraduate and postgraduate training is from Colorado University and his Stanford graduate degree focused on biomedical policy. He completed Stanford’s Executive Management Program and has published 50 papers and edited a book on best management practices for non-profit organizations.
Dr. Scott is a committee member for the International Society of Stem Cell Research and a member of the Center for Biomedical Ethics at Stanford. He is a past member of the Stanford Program in Genomics, Ethics and Society; the California Health Care Initiative;, and the Bay Area Bioscience Center. He has lectured at numerous universities and directs two courses in stem cell biology at Stanford University. He has been featured in national and local media coverage of these and other issues, including ABC, NBC, CBS, Time, U.S. News and World Report, Boston Globe, The Atlantic Monthly, National Public Radio’s “Fresh Air,” “Talk of the Nation,” and “TechNation,” KQED’s “Perspectives and Forum,” UPI, and Fox News.
 |
Evan Y. Snyder, M.D., Ph.D.
·Professor and Program Director,
Stem Cells and Regeneration Program
Burnham Institute for Medical Research |
Dr. Snyder earned his M.D. and his Ph.D. in Neuroscience from the University of Pennsylvania in 1980. He completed residencies in Pediatrics and Neurology at Children's Hospital-Boston, Harvard Medical School, and postdoctoral research at Harvard Medical School. In 1992, Snyder was appointed an instructor in Neurology at Harvard Medical School and was promoted to assistant professor in 1996. He is regarded as one of the fathers of the stem cell field, having identified over two decades ago that cells that came to be called stem cells were a source of neural plasticity. He was the first to demonstrate that non-hematopoietic stem cells could mediate cell and gene replacement, home to injury, and perform protective, trophic, pro-regenerative, and anti-inflammatory actions. He was the first to isolate human neural stem cells. In 2003, after 23 years at Harvard, Dr. Snyder was recruited to the Burnham Institute as professor and director of the Stem Cells and Regeneration program. |
|
 |
